These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 22820970)
1. Use of targeted therapy for refractory ALK-positive anaplastic large cell lymphoma as a bridging strategy prior to allogeneic transplantation. Ordemann R; Stöhlmacher J; Beuthien-Baumann B; Platzek I; van den Hoff J; Kroschinsky F; Middeke JM; Platzbecker U; Zietz C; Bornhäuser M; Ehninger G Ann Hematol; 2013 Jan; 92(1):125-7. PubMed ID: 22820970 [No Abstract] [Full Text] [Related]
2. Extended retreatment with brentuximab vedotin (SGN-35) maintains complete remission in patient with recurrent systemic anaplastic large-cell lymphoma. Foyil KV; Kennedy DA; Grove LE; Bartlett NL; Cashen AF Leuk Lymphoma; 2012 Mar; 53(3):506-7. PubMed ID: 21867368 [No Abstract] [Full Text] [Related]
3. Combined PD-1 and JAK1/2 inhibition in refractory primary mediastinal B-cell lymphoma. Nijland M; van Meerten T; Seitz A; Huls G; Kibbelaar R; Visser L; van den Berg A; Diepstra A Ann Hematol; 2018 May; 97(5):905-907. PubMed ID: 29327077 [No Abstract] [Full Text] [Related]
4. Safety and effective salvage regimen comprising a novel combination of brentuximab vedotin, L-asparaginase, and dexamethasone for refractory anaplastic large cell lymphoma, anaplastic lymphoma kinase negative. Kawamoto K; Suzuki T; Kasami T; Kiryu M; Sone H; Miyoshi H; Ohshima K; Takizawa J Hematol Oncol; 2019 Apr; 37(2):212-214. PubMed ID: 30394560 [No Abstract] [Full Text] [Related]
6. The combination of thalidomide, cyclophosphamide and dexamethasone is potentially useful in highly resistant Hodgkin's lymphoma. García-Sanz R; González-López TJ; Vázquez L; Hermida G; Graciani IF; San Miguel JF Eur J Haematol; 2010 Mar; 84(3):266-70. PubMed ID: 19912314 [TBL] [Abstract][Full Text] [Related]
7. Treatment outcome in children and adolescents with relapsed Hodgkin lymphoma--results of the UK HD3 relapse treatment strategy. Shankar A; Hayward J; Kirkwood A; McCarthy K; Hewitt M; Morland B; Daw S Br J Haematol; 2014 May; 165(4):534-44. PubMed ID: 24754633 [TBL] [Abstract][Full Text] [Related]
9. Intensification treatment based on early FDG-PET in patients with high-risk diffuse large B-cell lymphoma: a phase II GELTAMO trial. Pardal E; Coronado M; Martín A; Grande C; Marín-Niebla A; Panizo C; Bello JL; Conde E; Hernández MT; Arranz R; Bargay J; González-Barca E; Pérez-Ceballos E; Montes-Moreno S; Caballero MD Br J Haematol; 2014 Nov; 167(3):327-36. PubMed ID: 25066542 [TBL] [Abstract][Full Text] [Related]
10. Intensified therapy followed by autologous stem-cell transplantation (ASCT) versus conventional therapy as first-line treatment of follicular lymphoma: a meta-analysis. Wang B; Ren C; Zhang W; Ma X; Xia B; Sheng Z Hematol Oncol; 2013 Mar; 31(1):29-33. PubMed ID: 22488650 [TBL] [Abstract][Full Text] [Related]
11. [Intensive treatment of T-cell-rich B lymphoma]. Azaceta G; Palomera L; Varo MJ; Soria J Sangre (Barc); 1998 Feb; 43(1):94-5. PubMed ID: 9577190 [No Abstract] [Full Text] [Related]
12. High-dose chemotherapy and autologous transplantation in lymphomatous polyposis in second remission: three case reports and literature review. Popescu RA; Wotherspoon AC; Cunningham D Bone Marrow Transplant; 1998 Jul; 22(1):103-6. PubMed ID: 9678804 [TBL] [Abstract][Full Text] [Related]
13. Crizotinib in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma in the setting of renal insufficiency: a case report. Kothari S; Ud-Din N; Lisi M; Coyle T J Med Case Rep; 2016 Jun; 10():176. PubMed ID: 27301488 [TBL] [Abstract][Full Text] [Related]
14. Predictive value of (18)F-FDG hybrid PET/CT for the clinical outcome in patients with non-Hodgkin's lymphoma prior to and after autologous stem cell transplantation. Qiao W; Zhao J; Wang C; Wang T; Xing Y Hematology; 2010 Feb; 15(1):21-7. PubMed ID: 20132658 [TBL] [Abstract][Full Text] [Related]
15. Successful allogeneic stem cell transplantation for an adult with refractory anaplastic lymphoma kinase-positive anaplastic large cell lymphoma. Chen CH; Chen SW; Shen WL; Chen TY; Tsao CJ; Huang WT Int J Hematol; 2007 Feb; 85(2):105-7. PubMed ID: 17321986 [TBL] [Abstract][Full Text] [Related]
16. Successful allogeneic stem cell transplantation for Lennert lymphoma. Uni M; Yoshimi A; Nakamura F; Takazawa Y; Fukayama M; Kurokawa M Ann Hematol; 2013 Jun; 92(6):859-60. PubMed ID: 23224245 [No Abstract] [Full Text] [Related]
17. Value of frontline autologous stem-cell transplantation in peripheral T-cell lymphoma. Gutierrez A; Rodriguez J Ann Oncol; 2008 Aug; 19(8):1512. PubMed ID: 18662957 [No Abstract] [Full Text] [Related]
18. Effective autologous peripheral blood stem cell transplantation in plasma cell leukemia followed by T-large granular lymphocyte expansion: a case report. Sajeva MR; Greco MM; Cascavilla N; D'Arena G; Scalzulli P; Melillo L; Minervini MM; Bonini A; Di Mauro L; Carotenuto M; Musto P Bone Marrow Transplant; 1996 Jul; 18(1):225-7. PubMed ID: 8832022 [TBL] [Abstract][Full Text] [Related]
19. Pseudo-bowel obstruction due to varicella zoster virus infection after autologous stem cell transplantation. Precupanu CM; Girodet J; Mariani P; Zanni M; Mathiot C; Escande MC; Brault P; Decaudin D Am J Hematol; 2009 Feb; 84(2):127-8. PubMed ID: 19127592 [No Abstract] [Full Text] [Related]
20. Treatment of relapsed non-Hodgkin's lymphoma after BEAM chemotherapy and autologous transplantation by BU/CY chemotherapy and salvage transplantation. Fetscher S; Lübbert M; Kanz L; Behringer D; Finke J; Mertelsmann R; Lange W Bone Marrow Transplant; 1997 Mar; 19(5):527-8. PubMed ID: 9052926 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]